Elekta names ex-Nokia exec Savander CEO
This article was originally published in Clinica
Executive Summary
Swedish radiotherapy specialist Elekta has announced that ex-Nokia manager Niklas Savander will replace its current president and CEO Tomas Puusepp next May. Mr Savander joined Nokia – bought by US giant Microsoft earlier this year – in 1997, and was most recently a member of its executive management team. He left the Finnish company in June 2012 and, since then, has been a private equity adviser in Helsinki, Stockholm and London. Before joining Nokia, he worked for Hewlett-Packard. Outgoing CEO Mr Puusepp has been at Elekta since 1988, and will continue to serve on its board. The firm had a good first fiscal quarter and could soon break into the top 50 of the Clinica 100 (www.clinica.co.uk, 3 September 2013); Q2 results are due on 4 December.
You may also be interested in...
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
EuroPCR: Medtronic's drug-coated balloon keeps rising
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.